Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 7
2004 3
2005 5
2006 2
2007 9
2008 9
2009 10
2010 15
2011 15
2012 15
2013 8
2014 13
2015 10
2016 22
2017 15
2018 19
2019 18
2020 18
2021 12
2022 13
2023 10
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Results by year

Filters applied: . Clear all
Page 1
Proteolysis targeting chimeras (PROTACs) for epigenetics research.
Vogelmann A, Robaa D, Sippl W, Jung M. Vogelmann A, et al. Among authors: jung m. Curr Opin Chem Biol. 2020 Aug;57:8-16. doi: 10.1016/j.cbpa.2020.01.010. Epub 2020 Mar 5. Curr Opin Chem Biol. 2020. PMID: 32146413 Free article. Review.
Schistosome sirtuins as drug targets.
Lancelot J, Cabezas-Cruz A, Caby S, Marek M, Schultz J, Romier C, Sippl W, Jung M, Pierce RJ. Lancelot J, et al. Among authors: jung m. Future Med Chem. 2015;7(6):765-82. doi: 10.4155/fmc.15.24. Future Med Chem. 2015. PMID: 25996069 Free article. Review.
Frontiers in Medicinal Chemistry 2022 Goes Virtual.
Diamanti E, Méndez M, Ross T, Kuttruff CA, Lefranc J, Klingler FM, von Nussbaum F, Jung M, Gehringer M. Diamanti E, et al. Among authors: jung m. ChemMedChem. 2022 Nov 4;17(21):e202200419. doi: 10.1002/cmdc.202200419. Epub 2022 Oct 5. ChemMedChem. 2022. PMID: 36198574
HDAC8: a multifaceted target for therapeutic interventions.
Chakrabarti A, Oehme I, Witt O, Oliveira G, Sippl W, Romier C, Pierce RJ, Jung M. Chakrabarti A, et al. Among authors: jung m. Trends Pharmacol Sci. 2015 Jul;36(7):481-92. doi: 10.1016/j.tips.2015.04.013. Epub 2015 May 23. Trends Pharmacol Sci. 2015. PMID: 26013035 Free article. Review.
Cellular analysis of the action of epigenetic drugs and probes.
Hau M, Zenk F, Ganesan A, Iovino N, Jung M. Hau M, et al. Among authors: jung m. Epigenetics. 2017 May 4;12(5):308-322. doi: 10.1080/15592294.2016.1274472. Epub 2017 Jan 10. Epigenetics. 2017. PMID: 28071961 Free PMC article. Review.
[Editorial].
Dingermann T, Jung M, Sippl W. Dingermann T, et al. Among authors: jung m. Pharm Unserer Zeit. 2010 May;39(3):167. doi: 10.1002/pauz.201090023. Pharm Unserer Zeit. 2010. PMID: 20425768 German. No abstract available.
Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation.
Sinatra L, Vogelmann A, Friedrich F, Tararina MA, Neuwirt E, Colcerasa A, König P, Toy L, Yesiloglu TZ, Hilscher S, Gaitzsch L, Papenkordt N, Zhai S, Zhang L, Romier C, Einsle O, Sippl W, Schutkowski M, Gross O, Bendas G, Christianson DW, Hansen FK, Jung M, Schiedel M. Sinatra L, et al. Among authors: jung m. J Med Chem. 2023 Nov 9;66(21):14787-14814. doi: 10.1021/acs.jmedchem.3c01385. Epub 2023 Oct 30. J Med Chem. 2023. PMID: 37902787 Free PMC article.
239 results